Macrobian Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. With decades of collective experience in molecular neuroscience, the founders recognized the urgent need for innovative and effective treatments for Parkinson’s disease, a chronic disorder that affects millions of people worldwide. Their passion for advancing the field and improving patients’ quality of life inspired the creation of Macrobian Biotech. The company is currently housed at the Amsterdam Science Park, the heart of academic excellence in the Netherlands
Company Details
- Employees
- 3
- Founded
- -
- Address
- Science Park 904, Amsterdam,noord-Holland 1098,netherlands
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- macrobianbiotech.com
- HQ
- Amsterdam, Noord-Holland
Macrobian Biotech Questions
Macrobian Biotech's website is macrobianbiotech.com
Macrobian Biotech's LinkedIn profile is https://nl.linkedin.com/company/macrobianbiotech
Macrobian Biotech has
3 employees.
View email and phone details for 3
employees at Macrobian Biotech.
Macrobian Biotech's industry is
Research Services
Macrobian Biotech's top competitors are
Orca Therapeutics,
Lava Therapeutics N.v.,
Scenic Biotech,
Northsea Therapeutics,
Parkinnova Therapeutics,
Batavia Biosciences,
Leyden Labs,
Summa Biotech,
Lumicks,
Kling Biotherapeutics.
Macrobian Biotech's categories are Research Services
Macrobian Biotech's founding year is 2017
